Aventis Pharmaceuticals Inc.

Daniel N A Bezard

Michael L Edwards

Frank Halley

Andrew David Morley

Herve Bouchard

Dominique Damour

Conception Nemecek

Tahir Nadeem Majid

Paul Joseph Cox

Francois Clerc

Charles J Gardner

Shelley Amendola

Brian L Pedgrift

Timothy A Gillespy

Dorothea Kominos

Chantal Carrez

Christopher D Edlin

Justine Yeun Quai Lai

Olivier Houille

Stephanie Deprets

Stephanie D Deprets

The invention is directed to physiologically active compounds of general formula (I):&#x2014; and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.

Azaindoles for inhibiting aurora2 and other kinases

The invention is directed to physiologically active compounds of general formula (I):and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.

Azaindoles

Growing community of inventors

Bagnolet, France

Daniel N A Bezard